SeattleNTC is unique among interventional practices in its participation in multiple clinical trials and other research projects. We are not only trusted by training programs to teach the next generation of psychiatrists, we are also working to advance knowledge and therapeutics to help patients now and in the future. Our research teams works along side our clinical team to offer more options for patients with treatment resistant depression.
Which clinical trials are currently available for enrollment?
We are participating in the COMPASS trial for psilocybin.
We are also participating in the RECOVER VNS trial and are recruiting for bipolar disorder.
For more information on these studies, please reach out to us at email@example.com or call us at 206-467-6300 ext. 5.
Why participate in research?
SeattleNTC is currently participating in multiple clinical trials. This research may have direct, positive impact on patient care and quality of life for years to come. If you are not eligible or interested in one of our clinical treatment options, you could alternatively be a good candidate for a treatment option offered through one of these clinical trials.
How can I learn more?
If you would like more information about the research we do and the clinical trials we’re currently enrolling participants in, please reach out to us at firstname.lastname@example.org.